Skip to main content

Market Overview

Fulcrum Therapeutics, Inc. (FULC)

11.87 -0.05 (-0.42%)

Analyst Ratings

DateResearch FirmActionCurrentPT
3/22/21Credit SuisseInitiates Coverage OnOutperform26.0
3/08/21Morgan StanleyMaintainsEqual-Weight12.0
3/02/21StifelInitiates Coverage OnBuy18.0
11/10/20SVB LeerinkMaintainsOutperform23.0
10/16/20Piper SandlerInitiates Coverage OnOverweight22.0
8/12/20B of A SecuritiesDowngradesUnderperform11.0
8/12/20HC Wainwright & Co.MaintainsBuy20.0
8/12/20Morgan StanleyDowngradesEqual-Weight11.0
6/19/20B of A SecuritiesDowngradesNeutral23.0
6/17/20BTIGInitiates Coverage OnBuy27.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter